Members of our team had the opportunity to present a new poster abstract at NASP inSPIRE 2026, which was held from September 22-25, 2026.
CPS Authors
Andrew Wash, PharmD, PhD; Amanda Hickman, PharmD, MPH, MSCS; Amber Skrtic, PharmD, CSP; Khang Tran, PharmD; Mindy Roselli, PharmD; Natilee Azzara, PharmD, BCACP, CPh; Casey Fitzpatrick, PharmD; Ana I. Lopez-Medina, PharmD, PhD; Jessica Mourani, PharmD
Background
-
Migraine is a common and disabling condition where primary care providers (PCPs) are becoming a crucial access point for diagnosis and treatment due to the limited capacity of neurologists or headache specialists, with published wait times averaging approzimately 50 days but often variable and potentially longer in practice.1-3
-
However, PCPs report limited familiarity with expanding treatment options and may need support navigating access and ongoing patient management.1
-
Health-system specialty pharmacies' (HSSPs') expertise in these areas can strengthen effective migraine treatment and management in primary care.
Objectives
To describe the role and outcomes of specialty pharmacy (SP) support for migraine management in a primary care setting.
-
1
Callen E, Clay T, Alai J, et al. Migraine care practices in primary care: results from a national US survey. Fam Pract. 2024;41(3):277-282. doi:10.1093/fampra/cmad054
-
2
Minen MT, Malhotra NA, Waire EK, Swiderski HZ, Riggins NY, Sprouse-Blum AS. The American Headache Society First Contact-Headache in Primary Care program: current metrics, knowledge assessments, and direction for future initiatives. Headache. 2025;65(2):280-290. doi:10.1111/head.14852
-
3
Laffargue EK, Van Der Goes, DN, Wilson AM, Parziale SD, Sico JJ, Ney J. Neurology wait times after primary care or emergency department visits among the commercially insured population in the United States. Neurology. 2026;106(10):e218008. doi:10.1212/WNL.0000000000218008
